ProfileGDS4459 / ENSG00000163932
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 45% 39% 71% 41% 59% 66% 76% 66% 64% 69% 68% 67% 59% 43% 67% 50% 51% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.2745
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.0639
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 35.4671
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.2241
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.7659
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 65.0566
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 75.8376
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 85.0966
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 95.0364
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 105.3469
GSM623474group B, liver allograft wedge biopsie placebo treatment 15.1268
GSM623475group B, liver allograft wedge biopsie placebo treatment 25.2167
GSM623476group B, liver allograft wedge biopsie placebo treatment 34.7859
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.243
GSM623478group B, liver allograft wedge biopsie placebo treatment 55.267
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.3850
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.4351